Echo Therapeutics, Inc.
(Other OTC/NBB : ECTE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.97%160.340.7%$1256.04m
LLYEli Lilly & Co. -1.32%328.571.1%$1091.53m
ABBVAbbVie, Inc. -0.78%139.201.9%$853.86m
PFEPfizer Inc. -1.83%42.300.9%$788.54m
BMYBristol-Myers Squibb Co. -0.16%70.131.0%$750.62m
MRKMerck & Co., Inc. 0.27%87.680.7%$699.57m
AZNAstraZeneca Plc 1.63%55.811.0%$392.52m
ALNYAlnylam Pharmaceuticals, Inc. -1.88%198.578.2%$220.60m
GSKGSK Plc 0.68%30.210.3%$209.98m
NVSNovartis AG -0.41%75.730.2%$200.09m
HZNPHorizon Therapeutics Plc -3.52%65.505.4%$182.06m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$178.81m
IDXXIDEXX Laboratories, Inc. -3.49%333.943.9%$177.90m
SRPTSarepta Therapeutics, Inc. -1.72%112.8512.4%$139.30m
AKROAkero Therapeutics, Inc. -1.50%38.670.0%$132.15m

Company Profile

Echo Therapeutics is a medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Symphony® CGM System as a non-invasive, wireless, continuous glucose monitoring system for use in hospital critical care units and for people with diabetes. The Prelude® SkinPrep System, a component of their Symphony CGM System, allows for enhanced skin permeation that will enable extraction of analytes, such as glucose, and transdermal drug delivery.